unlimit health Company Information
Company Number
11775313
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Other personal service activities n.e.c.
Registered Address
edinburgh house, 3rd floor, edinburgh house, london, SE11 5DP
unlimit health Estimated Valuation
Pomanda estimates the enterprise value of UNLIMIT HEALTH at £3.3m based on a Turnover of £4.4m and 0.74x industry multiple (adjusted for size and gross margin).
unlimit health Estimated Valuation
Pomanda estimates the enterprise value of UNLIMIT HEALTH at £0 based on an EBITDA of £-4m and a 4.86x industry multiple (adjusted for size and gross margin).
unlimit health Estimated Valuation
Pomanda estimates the enterprise value of UNLIMIT HEALTH at £27.6m based on Net Assets of £14.1m and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Unlimit Health Overview
Unlimit Health is a live company located in london, SE11 5DP with a Companies House number of 11775313. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in January 2019, it's largest shareholder is unknown. Unlimit Health is a young, small sized company, Pomanda has estimated its turnover at £4.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Unlimit Health Health Check
Pomanda's financial health check has awarded Unlimit Health a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs


4 Strong

1 Regular

5 Weak

Size
annual sales of £4.4m, make it larger than the average company (£845.4k)
£4.4m - Unlimit Health
£845.4k - Industry AVG

Growth
3 year (CAGR) sales growth of -20%, show it is growing at a slower rate (8.2%)
-20% - Unlimit Health
8.2% - Industry AVG

Production
with a gross margin of 39.8%, this company has a comparable cost of product (39.8%)
39.8% - Unlimit Health
39.8% - Industry AVG

Profitability
an operating margin of -90.1% make it less profitable than the average company (5.8%)
-90.1% - Unlimit Health
5.8% - Industry AVG

Employees
with 25 employees, this is above the industry average (14)
25 - Unlimit Health
14 - Industry AVG

Pay Structure
on an average salary of £72.5k, the company has a higher pay structure (£29k)
£72.5k - Unlimit Health
£29k - Industry AVG

Efficiency
resulting in sales per employee of £177.2k, this is more efficient (£73.3k)
£177.2k - Unlimit Health
£73.3k - Industry AVG

Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Unlimit Health
- - Industry AVG

Creditor Days
its suppliers are paid after 5 days, this is quicker than average (37 days)
5 days - Unlimit Health
37 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Unlimit Health
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 105 weeks, this is more cash available to meet short term requirements (58 weeks)
105 weeks - Unlimit Health
58 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 41.8%, this is a higher level of debt than the average (37.7%)
41.8% - Unlimit Health
37.7% - Industry AVG
UNLIMIT HEALTH financials

Unlimit Health's latest turnover from March 2024 is £4.4 million and the company has net assets of £14.1 million. According to their latest financial statements, Unlimit Health has 25 employees and maintains cash reserves of £12.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
---|---|---|---|---|---|
Turnover | 4,430,117 | 10,246,040 | 7,316,193 | 8,651,273 | 6,735,532 |
Other Income Or Grants | |||||
Cost Of Sales | |||||
Gross Profit | |||||
Admin Expenses | |||||
Operating Profit | |||||
Interest Payable | |||||
Interest Receivable | |||||
Pre-Tax Profit | -3,203,357 | 1,087,132 | -4,277,109 | -369,587 | 20,823,908 |
Tax | |||||
Profit After Tax | -3,203,357 | 1,087,132 | -4,277,109 | -369,587 | 20,823,908 |
Dividends Paid | |||||
Retained Profit | -3,203,357 | 1,087,132 | -4,277,109 | -369,587 | 20,823,908 |
Employee Costs | 1,812,733 | 1,630,747 | 1,679,550 | 1,581,148 | 892,789 |
Number Of Employees | 25 | 26 | 27 | 26 | 23 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
---|---|---|---|---|---|
Tangible Assets | 1,586 | 3,966 | 6,345 | ||
Intangible Assets | |||||
Investments & Other | 11,342,187 | 10,702,758 | 3,233,316 | 2,980,938 | |
Debtors (Due After 1 year) | |||||
Total Fixed Assets | 11,343,773 | 10,706,724 | 3,239,661 | 2,980,938 | |
Stock & work in progress | |||||
Trade Debtors | 839 | 25,059 | 96,093 | 118,381 | |
Group Debtors | |||||
Misc Debtors | 384,061 | 245,779 | 797,262 | 2,195,891 | 7,179,675 |
Cash | 12,412,940 | 17,560,060 | 28,451,516 | 15,582,752 | 13,887,204 |
misc current assets | |||||
total current assets | 12,797,001 | 17,806,678 | 29,273,837 | 17,874,736 | 21,185,260 |
total assets | 24,140,774 | 28,513,402 | 32,513,498 | 20,855,674 | 21,185,260 |
Bank overdraft | |||||
Bank loan | |||||
Trade Creditors | 38,458 | 370,073 | 237,146 | 46,381 | 44,499 |
Group/Directors Accounts | |||||
other short term finances | |||||
hp & lease commitments | |||||
other current liabilities | 6,103,834 | 5,339,287 | 11,603,250 | 354,972 | 316,853 |
total current liabilities | 6,142,292 | 5,709,360 | 11,840,396 | 401,353 | 361,352 |
loans | |||||
hp & lease commitments | |||||
Accruals and Deferred Income | 3,937,495 | 5,539,698 | 4,495,890 | ||
other liabilities | |||||
provisions | |||||
total long term liabilities | 3,937,495 | 5,539,698 | 4,495,890 | ||
total liabilities | 10,079,787 | 11,249,058 | 16,336,286 | 401,353 | 361,352 |
net assets | 14,060,987 | 17,264,344 | 16,177,212 | 20,454,321 | 20,823,908 |
total shareholders funds | 14,060,987 | 17,264,344 | 16,177,212 | 20,454,321 | 20,823,908 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
---|---|---|---|---|---|
Operating Activities | |||||
Operating Profit | |||||
Depreciation | 3,172 | 793 | 793 | ||
Amortisation | |||||
Tax | |||||
Stock | |||||
Debtors | 137,443 | -575,703 | -1,469,663 | -5,006,072 | 7,298,056 |
Creditors | -331,615 | 132,927 | 190,765 | 1,882 | 44,499 |
Accruals and Deferred Income | -837,656 | -5,220,155 | 15,744,168 | 38,119 | 316,853 |
Deferred Taxes & Provisions | |||||
Cash flow from operations | |||||
Investing Activities | |||||
capital expenditure | |||||
Change in Investments | 639,429 | 7,469,442 | 252,378 | 2,980,938 | |
cash flow from investments | -639,429 | -7,469,442 | -252,378 | -2,980,938 | |
Financing Activities | |||||
Bank loans | |||||
Group/Directors Accounts | |||||
Other Short Term Loans | |||||
Long term loans | |||||
Hire Purchase and Lease Commitments | |||||
other long term liabilities | |||||
share issue | |||||
interest | |||||
cash flow from financing | |||||
cash and cash equivalents | |||||
cash | -5,147,120 | -10,891,456 | 12,868,764 | 1,695,548 | 13,887,204 |
overdraft | |||||
change in cash | -5,147,120 | -10,891,456 | 12,868,764 | 1,695,548 | 13,887,204 |
unlimit health Credit Report and Business Information
Unlimit Health Competitor Analysis

Perform a competitor analysis for unlimit health by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other small companies, companies in SE11 area or any other competitors across 12 key performance metrics.
unlimit health Ownership
UNLIMIT HEALTH group structure
Unlimit Health has no subsidiary companies.
Ultimate parent company
UNLIMIT HEALTH
11775313
unlimit health directors
Unlimit Health currently has 9 directors. The longest serving directors include Dr Justine Frain (Jan 2019) and Mr Jonathan Gorrie (Apr 2019).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Justine Frain | England | 69 years | Jan 2019 | - | Director |
Mr Jonathan Gorrie | England | 61 years | Apr 2019 | - | Director |
Mr Maximillian Seunik | England | 33 years | Jul 2022 | - | Director |
Ms Kathryn Ager | England | 56 years | Jul 2022 | - | Director |
Ms Arielle Dolegui | England | 37 years | Jul 2022 | - | Director |
Ms Abena Afari | England | 44 years | Jul 2024 | - | Director |
Ms Carolynne Wheeler Mackinnon | England | 49 years | Jul 2024 | - | Director |
Professor Samba Sow | England | 60 years | Nov 2024 | - | Director |
Dr Camilla Ducker | England | 48 years | Nov 2024 | - | Director |
P&L
March 2024turnover
4.4m
-57%
operating profit
-4m
0%
gross margin
39.9%
-2.27%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
14.1m
-0.19%
total assets
24.1m
-0.15%
cash
12.4m
-0.29%
net assets
Total assets minus all liabilities
unlimit health company details
company number
11775313
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
96090 - Other personal service activities n.e.c.
incorporation date
January 2019
age
6
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
sci foundation (March 2023)
accountant
-
auditor
HAYSMACINTYRE LLP
address
edinburgh house, 3rd floor, edinburgh house, london, SE11 5DP
Bank
BARCLAYS BANK PLC
Legal Advisor
RUSSELL-COOKE LLP
unlimit health Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to unlimit health.
unlimit health Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for UNLIMIT HEALTH. This can take several minutes, an email will notify you when this has completed.
unlimit health Companies House Filings - See Documents
date | description | view/download |
---|